{"id":"W1874041614","doi":"10.1111/dom.12469","title":"Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Janssen Biotech; Novo Nordisk; Merck; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Metformin; Placebo; Randomized controlled trial; Type 2 diabetes; Clinical endpoint; Confidence interval; Internal medicine; Diabetes mellitus; Insulin; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001914108,0.001364145,0.003965382,0.0004754521,0.0003496894,0.001174723,0.0008204217,0.002120585,0.004154969],"category_scores_gemma":[0.001969752,0.0008235737,0.001955333,0.0004396093,0.0008614418,0.001297,0.0004313987,0.002684987,0.0006972798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003976585,"about_ca_system_score_gemma":0.0005374018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004345901,"about_ca_topic_score_gemma":0.0007339232,"domain_scores_codex":[0.999285,0.0003695372,0.00007246259,0.0001379675,0.00006441723,0.00007059657],"domain_scores_gemma":[0.9990434,0.0003012011,0.0002221693,0.00008585982,0.00005894709,0.0002884977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9844327,0.003543802,0.0004273041,0.0003948812,0.0006213951,0.0000249867,0.00002405063,0.0001259455,0.001556759,0.00003155504,0.0001918216,0.008624732],"study_design_scores_gemma":[0.9595885,0.03765589,0.001524439,0.0000246948,0.0003978756,0.0000218465,0.00001080943,0.0003082745,0.0001984134,0.00004878964,0.0002102845,0.00001017989],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990384,0.005362242,0.0004836876,0.0005379421,0.0005427259,0.001201974,0.0004524245,0.00008897933,0.0009460286],"genre_scores_gemma":[0.990914,0.002901669,0.0009816729,0.0008382356,0.0005656903,0.001688618,0.0004999521,0.0000176853,0.001592475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004154969,"threshold_uncertainty_score":0.0138998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01624373097752722,"score_gpt":0.2401176022098212,"score_spread":0.223873871232294,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}